Kevin Warshs Potential Fed Policy Shift Could Reshape Wall Streets Market Operations Best HighYield Savings Rates Today Up to 410 APY Available as Fed Holds Rates Steady in 2026 Mastercard Partners With JDcom to Expand Global Payment Connectivity and Explore AIPowered Purchasing Solutions Should You Roll a 60000 State Pension into a Roth TSP Key Considerations for Federal Employees April US Payrolls Surge Past Expectations Yet Underlying Red Flags Emerge SK Hynix Surpasses 1 Trillion Market Cap as AI Demand Drives Chip Rally Rapid7 Q1 2026 Earnings EPS Surprises with 1765 Beat as Profitability Strengthens EQH Q1 2026 Earnings EPS Slightly Misses Estimates Amid Market Challenges BCML Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency INFU Q1 2026 Earnings Strong EPS Beat Offsets Cautious Market Sentiment BTBT Q1 2026 Earnings Massive EPS Miss as Bit Digital Reports DeeperThanExpected Loss GECCO Q1 2026 Earnings Earnings Beat Driven by Strong Portfolio Income Notes Rise Slightly SPX Technologies SPXC Holds Near 208 After Modest Gain Key Resistance in Sight Cheetah Net Supply Chain Service Inc CTNT Faces Minor Pullback Holds Above Key Support Independent Bank Corporation IBCP Holds Steady Near Support as Bank Sector Faces Mixed Signals Biodexa Pharmaceuticals BDRX Bounces 244 as Price Tests Key Resistance at 353 Summit State Bank SSBI Holds Steady Navigating a Narrow Trading Band DRAM ETFs Record Growth Highlights Memory Chip Bottleneck in AI Buildout Tiptree Inc TIPT Q2 2025 Earnings Strong Earnings Per Share Amid Quiet Quarter Stifel Financial SF Holds Steady Near 7255 as Market Sentiment Remains Cautious AvePoint AVPT Shows Modest Gains as Stock Hovers Near Key Resistance Sinclair Inc SBGI Gains 12 Approaching Key Resistance at 1502 CocaCola KO Edges Higher as Stability Prevails Tarsus Pharmaceuticals TARS Shows Resilience Near Support After Moderate Decline PMGC Holdings ELAB Surges 1098 Breaking Above Support Testing Key Resistance Alamos Gold AGI Declines Over 2 as Gold Sector Faces Headwinds Support Levels in Focus Pacific Biosciences PACB Edges Higher But Key Resistance Remains a Hurdle